PUBLICATION

TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy

Authors
Kim, M., Lu, L., Dvornikov, A.V., Ma, X., Ding, Y., Zhu, P., Olson, T.M., Lin, X., Xu, X.
ID
ZDB-PUB-210603-33
Date
2021
Source
International Journal of Molecular Sciences   22(11): (Journal)
Registered Authors
Ding, Yonghe, Lin, Xueying, Xu, Xiaolei, Zhu, Ping
Keywords
RagCS75Y, Rags, TFEB, cardiomyopathy, mTOR
MeSH Terms
  • Active Transport, Cell Nucleus
  • Amino Acid Substitution
  • Animals
  • Autophagy
  • Base Sequence
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/biosynthesis
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/physiology*
  • Cardiomyopathy, Dilated/genetics*
  • Cardiomyopathy, Dilated/therapy
  • Cells, Cultured
  • Gain of Function Mutation*
  • Gene Knock-In Techniques
  • Gene Knockout Techniques
  • Heart Ventricles/cytology
  • Humans
  • Mice
  • Monomeric GTP-Binding Proteins/genetics*
  • Monomeric GTP-Binding Proteins/physiology
  • Mutation, Missense*
  • Myocytes, Cardiac/metabolism
  • Phenotype
  • Point Mutation*
  • Rats, Wistar
  • Recombinant Proteins/metabolism
  • Signal Transduction
  • TOR Serine-Threonine Kinases/antagonists & inhibitors*
  • Transcription Activator-Like Effector Nucleases
  • Zebrafish
  • Zebrafish Proteins/deficiency
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/physiology
PubMed
34071043 Full text @ Int. J. Mol. Sci.
Abstract
A de novo missense variant in Rag GTPase protein C (RagCS75Y) was recently identified in a syndromic dilated cardiomyopathy (DCM) patient. However, its pathogenicity and the related therapeutic strategy remain unclear. We generated a zebrafish RragcS56Y (corresponding to human RagCS75Y) knock-in (KI) line via TALEN technology. The KI fish manifested cardiomyopathy-like phenotypes and poor survival. Overexpression of RagCS75Y via adenovirus infection also led to increased cell size and fetal gene reprogramming in neonatal rat ventricle cardiomyocytes (NRVCMs), indicating a conserved mechanism. Further characterization identified aberrant mammalian target of rapamycin complex 1 (mTORC1) and transcription factor EB (TFEB) signaling, as well as metabolic abnormalities including dysregulated autophagy. However, mTOR inhibition failed to ameliorate cardiac phenotypes in the RagCS75Y cardiomyopathy models, concomitant with a failure to promote TFEB nuclear translocation. This observation was at least partially explained by increased and mTOR-independent physical interaction between RagCS75Y and TFEB in the cytosol. Importantly, TFEB overexpression resulted in more nuclear TFEB and rescued cardiomyopathy phenotypes. These findings suggest that S75Y is a pathogenic gain-of-function mutation in RagC that leads to cardiomyopathy. A primary pathological step of RagCS75Y cardiomyopathy is defective mTOR-TFEB signaling, which can be corrected by TFEB overexpression, but not mTOR inhibition.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping